These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 9496533)

  • 1. An image analysis study of vastus lateralis muscle fibers in malignant hyperthermia susceptible patients.
    Zukowski F; De Craemer D; Van den Branden C; De Cauwer H; Heytens L; Martin JJ
    Clin Neuropathol; 1998; 17(1):6-11. PubMed ID: 9496533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Incidence of disposition for malignant hyperthermia in patients with neuromuscular diseases].
    Wappler F; Scholz J; von Richthofen V; Fiege M; Köchling A; Matschke J; Winkler G; Schulte am Esch J
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1998 Jun; 33(6):373-80. PubMed ID: 9689395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ryanodine contracture threshold times for diagnosis of malignant hyperthermia susceptibility: an experimental approach from a single laboratory.
    Weisshorn R; Wappler F; Fiege M; Gerbershagen MU; Kolodzie K; Alberts P; Horn EP; Schulte Am Esch J
    J Clin Anesth; 2004 Aug; 16(5):353-7. PubMed ID: 15374556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In-vitro-effects of cocaine in skeletal muscle specimens of patients susceptible to malignant hyperthermia].
    Weisshorn R; Wappler F; Fiege M; Gerbershagen M; Schulte Am Esch J
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2002 Mar; 37(3):138-43. PubMed ID: 11889614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscle biopsy and in vitro contracture test in subjects with idiopathic HyperCKemia.
    Malandrini A; Orrico A; Gaudiano C; Gambelli S; Galli L; Berti G; Tegazzin V; Dotti MT; Federico A; Sorrentino V
    Anesthesiology; 2008 Oct; 109(4):625-8. PubMed ID: 18813041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiminicore disease in a family susceptible to malignant hyperthermia: histology, in vitro contracture tests, and genetic characterization.
    Guis S; Figarella-Branger D; Monnier N; Bendahan D; Kozak-Ribbens G; Mattei JP; Lunardi J; Cozzone PJ; Pellissier JF
    Arch Neurol; 2004 Jan; 61(1):106-13. PubMed ID: 14732627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histomorphologic examination of skeletal muscle preparations does not differentiate between malignant hyperthermia-susceptible and -normal patients.
    von Breunig F; Wappler F; Hagel C; von Richthofen V; Fiege M; Weisshorn R; Stavrou D; Schulte am Esch J
    Anesthesiology; 2004 Apr; 100(4):789-94. PubMed ID: 15087612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Israeli Diagnostic Center for Malignant Hyperthermia: 7-years' accumulated experience.
    Glauber V; Ben Abraham R; Zweig A; Perel A
    Isr J Med Sci; 1997 Oct; 33(10):643-7. PubMed ID: 9397136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of malignant hyperthermia episodes with the Clinical Grading Scale].
    von Richthofen V; Wappler F; Scholz J; Fiege M; Schulte am Esch J
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1998 Apr; 33(4):244-9. PubMed ID: 9617423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic analysis with calcium-induced calcium release test in Japanese malignant hyperthermia susceptible (MHS) families.
    Maehara Y; Mukaida K; Hiyama E; Morio M; Kawamoto M; Yuge O
    Hiroshima J Med Sci; 1999 Mar; 48(1):9-15. PubMed ID: 10213958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An in-vivo metabolic test for detecting malignant hyperthermia susceptibility in humans: a pilot study.
    Schuster F; Metterlein T; Negele S; Kranke P; Muellenbach RM; Schwemmer U; Roewer N; Anetseder M
    Anesth Analg; 2008 Sep; 107(3):909-14. PubMed ID: 18713904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Is a presymptomatic malignant hyperthermia in-vitro diagnosis with 4-chloro-3-ethyl phenol possible? A study using porcine skeletal preparations].
    Gerbershagen MU; Wappler F; Fiege M; Weisshorn R; Kolodzie K; Schulte am Esch J
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2004 Feb; 39(2):81-6. PubMed ID: 14767797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myosin heavy-chain isoform distribution, fibre-type composition and fibre size in skeletal muscle of patients on haemodialysis.
    Molsted S; Eidemak I; Sorensen HT; Kristensen JH; Harrison A; Andersen JL
    Scand J Urol Nephrol; 2007; 41(6):539-45. PubMed ID: 17853024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Malignant hyperthermia of Duchenne muscular dystrophy: application of clinical grading scale and caffeine contracture of skinned muscle fibers].
    Takagi A
    Rinsho Shinkeigaku; 2000 May; 40(5):423-7. PubMed ID: 11002722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuromuscular partitioning, architectural design, and myosin fiber types of the M. vastus lateralis of the llama (Lama glama).
    Graziotti GH; Palencia P; Delhon G; Rivero JL
    J Morphol; 2004 Nov; 262(2):667-81. PubMed ID: 15376272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testosterone-induced increase in muscle size in healthy young men is associated with muscle fiber hypertrophy.
    Sinha-Hikim I; Artaza J; Woodhouse L; Gonzalez-Cadavid N; Singh AB; Lee MI; Storer TW; Casaburi R; Shen R; Bhasin S
    Am J Physiol Endocrinol Metab; 2002 Jul; 283(1):E154-64. PubMed ID: 12067856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discordant light microscopic, electron microscopic, and in vitro contracture study findings in a family with central core disease.
    De Cauwer H; Heytens L; Lübke U; Ceuterick C; Martin JJ
    Clin Neuropathol; 1997; 16(5):237-42. PubMed ID: 9323448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlations between genotype and pharmacological, histological, functional, and clinical phenotypes in malignant hyperthermia susceptibility.
    Monnier N; Kozak-Ribbens G; Krivosic-Horber R; Nivoche Y; Qi D; Kraev N; Loke J; Sharma P; Tegazzin V; Figarella-Branger D; Roméro N; Mezin P; Bendahan D; Payen JF; Depret T; Maclennan DH; Lunardi J
    Hum Mutat; 2005 Nov; 26(5):413-25. PubMed ID: 16163667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preservation of in vitro muscle fiber function in dermatomyositis and inclusion body myositis: a single fiber study.
    Krivickas LS; Amato AA; Krishnan G; Murray AV; Frontera WR
    Neuromuscul Disord; 2005 May; 15(5):349-54. PubMed ID: 15833427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-associated decrease of type IIA/B human skeletal muscle fibers.
    Lee WS; Cheung WH; Qin L; Tang N; Leung KS
    Clin Orthop Relat Res; 2006 Sep; 450():231-7. PubMed ID: 16691139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.